FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308771485> ?p ?o ?g. }

• W4308771485 endingPage "404" @default.
• W4308771485 startingPage "389" @default.
• W4308771485 abstract "Ferroptosis is a newly identified form of regulated cell death that is driven by iron overload and uncontrolled lipid peroxidation, but the role of ferroptosis in cardiac microvascular dysfunction remains unclear. Isorhapontigenin (ISO) is an analog of resveratrol and possesses strong antioxidant capacity and cardiovascular-protective effects. Moreover, ISO has been shown to alleviate iron-induced oxidative damage and lipid peroxidation in mitochondria. Therefore, the current study aimed to explore the benefits of ISO treatment on cardiac microvascular dysfunction in diabetes and the possible mechanisms involved, with a focus on ferroptosis and mitochondria. Our data revealed that ISO treatment improved microvascular density and perfusion in db/db mice by mitigating vascular structural damage, normalizing nitric oxide (NO) production via endothelial NO synthase activation, and enhancing angiogenetic ability via vascular endothelial growth factor receptor 2 phosphorylation. PRDX2 was identified as a downstream target of ISO, and endothelial-specific overexpression of PRDX2 exerted effects on the cardiac microvascular function that were similar to those of ISO treatment. In addition, PRDX2 mediated the inhibitive effects of ISO treatment on ferroptosis by suppressing oxidative stress, iron overload, and lipid peroxidation. Further study suggested that mitochondrial dynamics and dysfunction contributed to ferroptosis, and ISO treatment or PRDX2 overexpression attenuated mitochondrial dysfunction via MFN2-dependent mitochondrial dynamics. Moreover, MFN2 overexpression suppressed the mitochondrial translocation of ACSL4, ultimately inhibiting mitochondria-associated ferroptosis. In contrast, enhancing mitochondria-associated ferroptosis via ACSL4 abolished the protective effects of ISO treatment on cardiac microcirculation. Taken together, the results of the present work demonstrated the beneficial effects of ISO treatment on cardiac microvascular protection in diabetes by suppressing mitochondria-associated ferroptosis through PRDX2-MFN2-ACSL4 pathways." @default.
• W4308771485 created "2022-11-15" @default.
• W4308771485 creator A5004289748 @default.
• W4308771485 creator A5010554147 @default.
• W4308771485 creator A5029969492 @default.
• W4308771485 creator A5033646176 @default.
• W4308771485 creator A5053300478 @default.
• W4308771485 creator A5053440485 @default.
• W4308771485 creator A5056248574 @default.
• W4308771485 creator A5071672663 @default.
• W4308771485 creator A5076118607 @default.
• W4308771485 creator A5081966786 @default.
• W4308771485 date "2022-11-11" @default.
• W4308771485 modified "2023-10-17" @default.
• W4308771485 title "Isorhapontigenin Attenuates Cardiac Microvascular Injury in Diabetes via the Inhibition of Mitochondria-Associated Ferroptosis Through PRDX2-MFN2-ACSL4 Pathways" @default.
• W4308771485 cites W1982753978 @default.
• W4308771485 cites W1997183854 @default.
• W4308771485 cites W2002490399 @default.
• W4308771485 cites W2011052121 @default.
• W4308771485 cites W2016331164 @default.
• W4308771485 cites W2019599344 @default.
• W4308771485 cites W2035898183 @default.
• W4308771485 cites W2076598575 @default.
• W4308771485 cites W2085628448 @default.
• W4308771485 cites W2123705280 @default.
• W4308771485 cites W2210151709 @default.
• W4308771485 cites W2395237205 @default.
• W4308771485 cites W2515712940 @default.
• W4308771485 cites W2549188196 @default.
• W4308771485 cites W2573212216 @default.
• W4308771485 cites W2601402626 @default.
• W4308771485 cites W2619512829 @default.
• W4308771485 cites W2745239458 @default.
• W4308771485 cites W2752235426 @default.
• W4308771485 cites W2777514005 @default.
• W4308771485 cites W2792926837 @default.
• W4308771485 cites W2804492778 @default.
• W4308771485 cites W2807481070 @default.
• W4308771485 cites W2809012217 @default.
• W4308771485 cites W2885864477 @default.
• W4308771485 cites W2903058414 @default.
• W4308771485 cites W2906319220 @default.
• W4308771485 cites W2908569218 @default.
• W4308771485 cites W2944511570 @default.
• W4308771485 cites W2950438903 @default.
• W4308771485 cites W2980622391 @default.
• W4308771485 cites W2999067083 @default.
• W4308771485 cites W3012453245 @default.
• W4308771485 cites W3020990397 @default.
• W4308771485 cites W3035851500 @default.
• W4308771485 cites W3041822635 @default.
• W4308771485 cites W3095384631 @default.
• W4308771485 cites W3095680891 @default.
• W4308771485 cites W3096385696 @default.
• W4308771485 cites W3125500727 @default.
• W4308771485 cites W3132006950 @default.
• W4308771485 cites W3169620467 @default.
• W4308771485 cites W3177084210 @default.
• W4308771485 cites W3185682642 @default.
• W4308771485 cites W3188913950 @default.
• W4308771485 cites W3204982646 @default.
• W4308771485 cites W3210464951 @default.
• W4308771485 cites W4200277427 @default.
• W4308771485 cites W4225302233 @default.
• W4308771485 cites W4288080614 @default.
• W4308771485 doi "https://doi.org/10.2337/db22-0553" @default.
• W4308771485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36367849" @default.
• W4308771485 hasPublicationYear "2022" @default.
• W4308771485 type Work @default.
• W4308771485 citedByCount "13" @default.
• W4308771485 countsByYear W43087714852023 @default.
• W4308771485 crossrefType "journal-article" @default.
• W4308771485 hasAuthorship W4308771485A5004289748 @default.
• W4308771485 hasAuthorship W4308771485A5010554147 @default.
• W4308771485 hasAuthorship W4308771485A5029969492 @default.
• W4308771485 hasAuthorship W4308771485A5033646176 @default.
• W4308771485 hasAuthorship W4308771485A5053300478 @default.
• W4308771485 hasAuthorship W4308771485A5053440485 @default.
• W4308771485 hasAuthorship W4308771485A5056248574 @default.
• W4308771485 hasAuthorship W4308771485A5071672663 @default.
• W4308771485 hasAuthorship W4308771485A5076118607 @default.
• W4308771485 hasAuthorship W4308771485A5081966786 @default.
• W4308771485 hasBestOaLocation W43087714852 @default.
• W4308771485 hasConcept C104317684 @default.
• W4308771485 hasConcept C134018914 @default.
• W4308771485 hasConcept C163950672 @default.
• W4308771485 hasConcept C185592680 @default.
• W4308771485 hasConcept C24586158 @default.
• W4308771485 hasConcept C2776151105 @default.
• W4308771485 hasConcept C2777092462 @default.
• W4308771485 hasConcept C2780829032 @default.
• W4308771485 hasConcept C2780972559 @default.
• W4308771485 hasConcept C28859421 @default.
• W4308771485 hasConcept C55493867 @default.
• W4308771485 hasConcept C86803240 @default.
• W4308771485 hasConcept C95444343 @default.
• W4308771485 hasConcept C98274493 @default.
• W4308771485 hasConceptScore W4308771485C104317684 @default.

• next